284 related articles for article (PubMed ID: 38618963)
21. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of haemangiomas of infancy with propranolol; good results, few side effects].
Hermans DJ; Ottenhof MJ; Wijnen MH; van Beynum IM; van der Horst CM; van der Vleuten CJ
Ned Tijdschr Geneeskd; 2011; 155(40):A3482. PubMed ID: 21988755
[TBL] [Abstract][Full Text] [Related]
23. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
26. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
27. Propranolol treatment for infantile hemangiomas.
Buckmiller LM
Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):458-9. PubMed ID: 19858718
[TBL] [Abstract][Full Text] [Related]
28. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
29. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
Storch CH; Hoeger PH
Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
[TBL] [Abstract][Full Text] [Related]
30. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease.
Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P
Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470
[TBL] [Abstract][Full Text] [Related]
31. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.
Mong EF; Akat KM; Canfield J; Lockhart J; VanWye J; Matar A; Tsibris JCM; Wu JK; Tuschl T; Totary-Jain H
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1321-1332. PubMed ID: 29724816
[TBL] [Abstract][Full Text] [Related]
32. Infantile hemangiomas: what have we learned from propranolol?
Hagen R; Ghareeb E; Jalali O; Zinn Z
Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
[TBL] [Abstract][Full Text] [Related]
33. Infantile Hemangioma: A Current Review.
Pahl KS; McLean TW
J Pediatr Hematol Oncol; 2022 Mar; 44(2):31-39. PubMed ID: 34966091
[TBL] [Abstract][Full Text] [Related]
34. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
35. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
36. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
[TBL] [Abstract][Full Text] [Related]
37. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution.
Itinteang T; Brasch HD; Tan ST; Day DJ
J Plast Reconstr Aesthet Surg; 2011 Jun; 64(6):759-65. PubMed ID: 20870476
[TBL] [Abstract][Full Text] [Related]
38. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
40. The role of propranolol in the treatment of infantile hemangioma.
Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF
Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
